Methods and compositions for cancer treatment
US-2024424094-A1 · Dec 26, 2024 · US
US10822606B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10822606-B2 |
| Application number | US-201415025217-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 29, 2014 |
| Priority date | Sep 27, 2013 |
| Publication date | Nov 3, 2020 |
| Grant date | Nov 3, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods, compositions, and kits are provided herein for CRISPER/Cas-mediated nucleic acid detection or modification.
Opening claim text (preview).
What is claimed is: 1. A method of genome imaging a target nucleic acid sequence in a living cell nucleus, the method comprising: (i) introducing into the living cell: (a) one or more small guide RNAs (sgRNAs) comprising sequences of SEQ ID NO:4, SEQ ID NO:8, and/or SEQ ID NO:17, wherein each of the sgRNAs is specific for the target nucleic acid sequence in the living cell nucleus; and (b) a first labeled nuclease-deficient Cas9 (dCas9), thereby forming a first labeled complex comprising at least one of the sgRNAs and the first labeled dCas9; and (ii) incubating the living cell to allow the first labeled complex to localize to the target nucleic acid sequence in the living cell nucleus; and (iii) imaging the presence or quantity of the first labeled complex in the nucleus of the living cell, thereby imaging the target nucleic acid. 2. The method of claim 1 , wherein the one or more sgRNAs comprise at least 2 different sgRNAs, each specific for a different portion of the target nucleic acid sequence. 3. The method of claim 1 , wherein the one or more sgRNAs are specific for a repeated target sequence. 4. The method of claim 1 , wherein the introducing further comprises forming a second labeled complex comprising the one or more sgRNAs and a second labeled dCas9; and contacting the living cell with the second labeled complex. 5. The method of claim 4 , wherein the first and second labeled complexes are specific for a different target nucleic acid sequence in the living cell nucleus or specific for a different region of a chromosome in the living cell nucleus. 6. The method of claim 4 , wherein the first and second labeled complexes are labeled with a different label, and the method comprises imaging the presence or quantity of the first and second labeled complexes in the nucleus of the living cell, thereby imaging the target nucleic acid. 7. A method of genome imaging a target nucleic acid sequence in a living cell nucleus, the method comprising: (i) introducing into the living cell: (a) one or more small guide RNAs (sgRNAs) comprising a sequence of SEQ ID NO:4 and/or SEQ ID NO:8, wherein each of the sgRNAs is specific for the target nucleic acid sequence in the living cell nucleus; and (b) a first labeled nuclease-deficient Cas9 (dCas9), thereby forming a first labeled complex comprising at least one of the sgRNAs and the first labeled dCas9; and (ii) incubating the living cell to allow the first labeled complex to localize to the target nucleic acid sequence in the living cell nucleus; and (iii) imaging the presence or quantity of the first labeled complex in the nucleus of the living cell, thereby imaging the target nucleic acid. 8. The method of claim 1 , wherein the one or more sgRNAs comprise SEQ ID NO:4. 9. The method of claim 1 , wherein the first labeled dCas9 comprises a Cas9 protein containing a mutation at one or more of the following residues: D10, G12, G17, E762, H840, N854, N863, H982, H983, A984, D986, or A987.
Ribonucleases {[RNase]; Deoxyribonucleases [DNase]} · CPC title
Type of nucleic acid · CPC title
involving clustered regularly interspaced short palindromic repeats [CRISPR] · CPC title
General methods applicable to biologically active non-coding nucleic acids · CPC title
Hydrolases acting on ester bonds (3.1) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.